Menu Close

Economy – Articles, Analysis, Opinion

Displaying 551 - 575 of 2452 articles

By pairing solar power and battery storage, hybrids can keep providing electricity after dark. Petmal via Getty Images

Meet the power plant of the future: Solar + battery hybrids are poised for explosive growth

The largest category of power plants applying to connect to the US grid are now solar, and over a third of those are hybrids that include battery storage.
Replacing ships like the Moskva will be pricey. The flagship of Russia’s Black Sea Fleet recently sank after suffering damage. Russian Defense Ministry Press Service via AP

Russia faces first foreign default since 1918 – here’s how it could complicate Putin’s ability to wage war in Ukraine

Russia is on the verge of defaulting on its foreign debt, which not only could have severe economic consequences but could also complicate Putin’s ability to wage a prolonged war in Ukraine.
Managers who abuse their employees may be suffering from a perceptual bias. imtmphoto/iStock via Getty Images

Abusive bosses often blame a worker’s lack of effort or care for poor performance when it’s their own biases that may be the problem

About 1 in 7 workers say their managers are abusive, whether it involves ridicule or a failure to provide credit when it’s due.
Building relationships with colleagues outside of work is important for career development. 10'000 Hours/Digital Vision via Getty Images

Fishing, strip clubs and golf: How male-focused networking in medicine blocks female colleagues from top jobs

By surveying over 100 people in academic medicine, a researcher found that women are consistently excluded from important networking activities like watching sports, drinking at bars and playing golf.
From thalidomide to Viagra, drug repurposing salvaged failed treatments by giving them new targets. smartboy10/DigitalVision Vectors via Getty Images

Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier

Drug repurposing can redeem failed treatments and squeeze out new uses from others. But many pharmaceutical companies are hesitant to retool existing drugs without a high return on investment.